Follow your Gut: Microbiome-Based Approaches in the Developmental Pipeline for the Prevention and Adjunctive Treatment of Clostridioides difficile Infection (CDI)

被引：0
|
作者：
A. J. Gonzales-Luna
T. J. Carlson
机构：
[1] University of Houston College of Pharmacy,Department of Pharmacy Practice and Translational Research
[2] High Point University Fred Wilson School of Pharmacy,Department of Clinical Sciences
来源：
Current Infectious Disease Reports | 2020年 / 22卷
关键词：
Recurrent CDI; Biotherapeutic; Microbiome; Pipeline; Prevention;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 13 条
  • [1] Follow your Gut: Microbiome-Based Approaches in the Developmental Pipeline for the Prevention and Adjunctive Treatment ofClostridioides difficileInfection (CDI)
    Gonzales-Luna, A. J.
    Carlson, T. J.
    CURRENT INFECTIOUS DISEASE REPORTS, 2020, 22 (08)
  • [2] Recurrent Clostridioides difficile Infection: Current Clinical Management and Microbiome-Based Therapies
    Berry, Parul
    Khanna, Sahil
    BIODRUGS, 2023, 37 (06) : 757 - 773
  • [3] Recurrent Clostridioides difficile Infection: Current Clinical Management and Microbiome-Based Therapies
    Parul Berry
    Sahil Khanna
    BioDrugs, 2023, 37 : 757 - 773
  • [4] Microbiome-based therapeutics for Clostridioides difficile infection: helpful solutions or unclear cocktails?
    Hota, Susy S.
    Poutanen, Susan M.
    LANCET INFECTIOUS DISEASES, 2023, 23 (09): : 999 - 1000
  • [5] Antibiotic Treatment Pipeline for Clostridioides difficile Infection (CDI): A Wide Array of Narrow-Spectrum Agents
    T. J. Carlson
    A. J. Gonzales-Luna
    Current Infectious Disease Reports, 2020, 22
  • [6] Microbiome-Related and Infection Control Approaches to Primary and Secondary Prevention of Clostridioides difficile Infections
    McFarland, Lynne V.
    Goldstein, Ellie J. C.
    Kullar, Ravina
    MICROORGANISMS, 2023, 11 (06)
  • [7] The Role of Microbiome-Based Therapeutics in Clostridioides difficile Infection: Durable, Long-Term Results of RBX2660
    Orenstein, Robert
    INFECTIOUS DISEASES AND THERAPY, 2023, 12 (01) : 1 - 7
  • [8] The Role of Microbiome-Based Therapeutics in Clostridioides difficile Infection: Durable, Long-Term Results of RBX2660
    Robert Orenstein
    Infectious Diseases and Therapy, 2023, 12 : 1 - 7
  • [9] REAL WORLD OUTCOMES OF A NOVEL FECAL MICROBIOME REPLACMENT TREATMENT FOR THE PREVENTION OF RECURRENT CLOSTRIDIOIDES DIFFICILE INFECTION: A MULTICENTER STUDY
    Ritter, Timothy
    Rosenberg, Jonathan
    Hengel, Richard L.
    Krishnan, Sujatha
    Baker, Kathy A.
    Van Anglen, Lucinda J.
    Hanna, Kelly
    Guo, Amy
    Moosapanah, Mielad
    Garey, Kevin W.
    GASTROENTEROLOGY, 2024, 166 (05) : S578 - S579
  • [10] Non-invasive treatment of Clostridioides difficile infection with a human-origin probiotic cocktail through gut microbiome-gut metabolome modulations
    Gurung, Bijay
    Courreges, Maria C.
    Pollak, Julie
    Malgor, Ramiro
    Jiang, Lin
    Wang, Bo
    Wang, Shaohua
    FRONTIERS IN MICROBIOLOGY, 2025, 16
12